Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed and Bevacizumab for Recurrent Ovarian and Primary Peritoneal Carcinoma
NCT00868192Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- May 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, bevacizumab in ovarian carcinoma, primary peritoneal carcinoma (PPC), sponsored by Washington University School of Medicine. Started May 2008; status: completed.
02
Drugs
pemetrexedbevacizumab
03
Conditions
ovarian carcinomaprimary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00868192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868192.